Skip to content
stoqly

Edgewell Personal Care

EPC NYSE Household Products Financials FY2016–FY2025

Edgewell Personal Care's revenue fell 1.3% to $2.2 billion in fiscal 2025. Its operating margin was 4.3%, down from 8.8% a year earlier. Free cash flow was $41 million. It paid out $120 million in dividends and buybacks, 289% of free cash flow. The diluted share count fell 5.0%.

Last close · Oct 23, 2026

$28.06

2.9%
Value it Compare
Revenue Total sales reported in the income statement.
$2.2B
1.3% vs prior year
Operating margin Operating income as a share of revenue.
4.3%
4.5 pts
Net income Profit after all expenses, interest and tax.
$25.4M
74.2%
Free cash flow Cash from operations minus capital spending.
$41.4M
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
3.6%
2.5 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$1.3B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
—

What Edgewell Personal Care does

No business description yet.

Legal name
EDGEWELL PERSONAL CARE COMPANY
Fiscal year ends
September 30, 2025
Latest annual report
—
Accession · CIK
0001628280-25-052765
0001096752

Revenue and margins

Edgewell Personal Care had $2.2B of revenue in fiscal 2025, down 1.3% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew −17.5% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $41.4M in fiscal 2025, 1.9% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Edgewell Personal Care returned $120M to shareholders in fiscal 2025, 289% of free cash flow. The diluted share count fell 5.0%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Edgewell Personal Care yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of −$1.2B and divides by 47.6M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Balance sheet

Cash, debt and the ratios that show how comfortably Edgewell Personal Care can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $479M$189M$216M$209M$226M
Debt incl. finance leases $1.3B$1.4B$1.4B$1.3B$1.4B
Net debt / EBITDA 2.4x4.5x3.6x3.7x6.3x
Debt / equity 0.8x1.0x0.9x0.8x0.9x
Interest coverage 3.5x2.6x2.9x2.6x1.3x
Current ratio 2.1x1.8x1.8x1.7x1.8x
Quick ratio 1.5x0.9x0.9x0.8x0.9x
Total assets $3.7B$3.7B$3.7B$3.7B$3.8B
Total liabilities $2.1B$2.2B$2.2B$2.1B$2.2B
Shareholders' equity $1.6B$1.5B$1.5B$1.6B$1.6B
Net debt (− = net cash) $771M$1.2B$1.2B$1.1B$1.2B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

1 insider

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
Nov 20, 2025 John M DunhamChief Accounting Officer Sold 333 $17.21 $0.0M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✓ ✓
Cash from operations is positive ✕ ✕ ✓
Return on assets rose ✓ ✕ ✕
Cash from operations exceeds net income ✕ ✕ ✓
Debt fell relative to assets ✓ ✓ ✕
Current ratio rose ✓ ✕ ✓
Share count didn't rise ✓ ✓ ✓
Gross margin rose ✓ ✓ ✕
Revenue rose relative to assets ✓ ✕ ✕
F-score 7 / 94 / 95 / 9
Accruals ratio 8.9%8.8%−2.5%
Altman Z'' 2.802.742.61

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Edgewell Personal Care EPC $1.3B −1.3% 4.3% 1.9% 3.6% — 5
Spectrum Brands SPB $1.8B −5.2% 4.5% 5.9% 5.3% 25.2x 6 Compare →
Energizer ENR $1.6B 2.3% — 2.1% 11.1% — 7 Compare →
Central Garden & Pet CENT $2.8B −2.2% 8.0% 9.3% 9.7% 16.8x 8 Compare →
Inter Parfums IPAR $3.7B 2.5% 18.2% 12.8% — 22.0x 4 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $2.4B $2.3B $2.2B $2.1B $1.9B $2.1B $2.2B $2.3B $2.3B $2.2B
Gross profit $1.2B $1.1B $1.0B $967M $881M $951M $881M $941M $956M $925M
Research and development $71.9M $67.6M $61.1M $53.5M $55.3M $57.8M $55.5M $58.5M $58.4M $57.6M
Operating income — — — $244M $176M $240M $182M $227M $199M $96.6M
Interest expense $71.8M $69.2M $68.0M $62.6M $61.2M $67.9M $71.4M $78.5M $76.5M $73.2M
Pretax income $220M −$52.9M $164M −$390M $87.3M $147M $124M $148M $121M $23.6M
Income tax $41.2M −$58.6M $60.5M −$18.1M $19.7M $29.3M $24.6M $33.0M $22.3M −$1.8M
Net income $179M $5.7M $103M −$372M $67.6M $118M $99.5M $115M $98.6M $25.4M
Diluted EPS $2.99 $0.10 $1.90 −$6.88 $1.24 $2.13 $1.85 $2.21 $1.97 $0.53
Diluted shares 0.06B 0.06B 0.05B 0.05B 0.05B 0.06B 0.05B 0.05B 0.05B 0.05B
Cash flow
Cash from operations $187M $314M $259M $191M $233M $229M $102M −$216M −$231M $118M
Capital expenditure $69.5M $69.0M $62.0M $58.0M $47.7M $56.8M $56.4M $49.5M $56.5M $77.0M
Free cash flow $117M $245M $197M $133M $185M $172M $45.6M −$266M −$288M $41.4M
Depreciation and amortization $92.6M $94.4M $97.6M $93.8M $88.8M $87.1M $89.9M $91.4M $88.0M $88.8M
Stock-based compensation $25.6M $22.2M $17.0M $17.8M $19.2M $27.3M $23.8M $27.5M $26.5M $24.5M
Acquisitions $0.0M $34.0M $90.2M $0.0M $234M $0.3M $309M $0.0M $0.0M $0.0M
Share buybacks $197M $165M $124M $0.0M $0.0M $9.2M $125M $75.2M $58.5M $90.2M
Dividends paid $0.0M $0.0M $0.0M $0.0M $0.0M $25.6M $32.6M $31.5M $30.7M $29.3M
Dividends and buybacks $197M $165M $124M $0.0M $0.0M $34.8M $158M $107M $89.2M $120M
Balance sheet
Cash and short-term investments $739M $503M $266M $342M $365M $479M $189M $216M $209M $226M
Total debt $1.8B $1.5B $1.3B $1.2B $1.3B $1.3B $1.4B $1.4B $1.3B $1.4B
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Current assets $1.5B $1.2B $951M $1.0B $984M $1.1B $942M $962M $936M $996M
Current liabilities $868M $524M $717M $660M $511M $537M $540M $523M $564M $566M
Inventory $309M $334M $330M $357M $314M $346M $449M $492M $477M $485M
Property and equipment, net $486M $453M $424M $396M $371M $363M $346M $338M $349M $369M
Total assets $4.8B $4.2B $4.0B $3.4B $3.5B $3.7B $3.7B $3.7B $3.7B $3.8B
Total liabilities $2.9B $2.4B $2.2B $2.1B $2.1B $2.1B $2.2B $2.2B $2.1B $2.2B
Shareholders' equity $1.8B $1.7B $1.7B $1.3B $1.4B $1.6B $1.5B $1.5B $1.6B $1.6B
Margins
Gross margin 49.1% 49.0% 46.2% 45.2% 45.2% 45.6% 40.5% 41.8% 42.4% 41.6%
Operating margin — — — 11.4% 9.0% 11.5% 8.4% 10.1% 8.8% 4.3%
EBITDA margin 16.3% 4.8% 14.7% 15.8% 13.6% 15.7% 12.5% 14.1% 12.8% 8.3%
Net margin 7.6% 0.3% 4.6% −17.4% 3.5% 5.6% 4.6% 5.1% 4.4% 1.1%
FCF margin 5.0% 10.6% 8.8% 6.2% 9.5% 8.3% 2.1% −11.8% −12.8% 1.9%
Returns
Return on capital 8.2% 0.5% 5.3% 7.8% 6.1% 8.2% 5.8% 6.6% 6.1% 3.6%
Return on capital employed 7.1% 0.4% 6.7% 8.1% 6.1% 7.8% 5.8% 7.1% 6.2% 3.0%
Return on equity 9.7% 0.3% 5.9% −24.4% 4.9% 7.8% 6.5% 7.6% 6.3% 1.6%
Return on assets 3.7% 0.1% 2.5% −10.1% 1.9% 3.3% 2.7% 3.1% 2.6% 0.7%
Growth
Revenue growth −2.5% −2.7% −2.8% −4.2% −8.9% 7.1% 4.0% 3.7% 0.1% −1.3%
Net income growth — −96.8% 1,712.3% −460.3% — 74.3% −15.5% 15.3% −14.0% −74.2%
EPS growth — −96.7% 1,800.0% −462.1% — 71.8% −13.2% 19.5% −10.9% −73.1%
FCF growth 137.5% 108.5% −19.3% −32.8% 39.4% −6.9% −73.5% −682.5% — —
Share count change −3.7% −3.7% −5.2% −0.7% 0.9% 1.1% −2.9% −3.4% −3.3% −5.0%
Financial health
Net debt / EBITDA 2.8x 9.2x 3.1x 2.6x 3.3x 2.4x 4.5x 3.6x 3.7x 6.3x
Debt / equity 1.0x 0.9x 0.7x 0.9x 0.9x 0.8x 1.0x 0.9x 0.8x 0.9x
Interest coverage 4.1x 0.2x 3.4x 3.9x 2.9x 3.5x 2.6x 2.9x 2.6x 1.3x
Current ratio 1.7x 2.3x 1.3x 1.6x 1.9x 2.1x 1.8x 1.8x 1.7x 1.8x
Quick ratio 1.3x 1.6x 0.9x 1.0x 1.3x 1.5x 0.9x 0.9x 0.8x 0.9x
Capital allocation
Capex / revenue 2.9% 3.0% 2.8% 2.7% 2.5% 2.7% 2.6% 2.2% 2.5% 3.5%
Stock comp / revenue 1.1% 1.0% 0.8% 0.8% 1.0% 1.3% 1.1% 1.2% 1.2% 1.1%
Payouts / FCF 167.6% 67.6% 63.0% 0.0% 0.0% 20.2% 346.3% — — 288.7%
Quality scores
Piotroski F-score 7.0 7.0 7.0 5.0 7.0 8.0 5.0 7.0 4.0 5.0
Altman Z'' 2.5 2.6 2.5 2.5 2.7 3.1 2.6 2.8 2.7 2.6
Accruals ratio −0.2% −6.9% −3.8% −15.3% −4.7% −3.1% −0.1% 8.9% 8.8% −2.5%

Source: SEC EDGAR XBRL filings (CIK 0001096752). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open